Tumor necrosis factor in the pathogenesis of infectious diseases

B. Beutler, G. E. Grau

Research output: Contribution to journalArticle

217 Citations (Scopus)

Abstract

Objectives: To review the immunologic role of the cytokines and the specific role that tumor necrosis factor (TNF) plays in response to infection. The influence of bacterial lipopolysaccharide on TNF, the cytokine cascade, and resultant pathologies are also reviewed. Data Sources: A MEDLINE search of the international English language literature from 1960 to the present was reviewed, but data from the past 5 yrs primarily formed the basis for this review. Study Selection: Those studies detailing the interaction of lipopolysaccharide, TNF, and other cytokines, and their roles in combating infection were emphasized. Investigations that described animal and human results served as the primary database. Data Extraction: Animal studies were selected based on the relevance of the model to the pathogenesis of the human clinical syndrome. Where they provided supportive evidence, patient studies were selected on the basis of study design. Data Synthesis: TNF plays a key role in the normal immune response to infection, limiting the spread of pathogens. Exaggerated physiologic responses occur under the influence of high concentrations of TNF that are released in response to overwhelming infection, resulting in aberrations in coagulation, cell adhesion, chemotaxis/transmigration, and vascular integrity. These pathologic effects may be inhibited by anti-TNF monoclonal antibodies and recombinant soluble receptor inhibitory proteins. Conclusions: TNF exerts both physiologic and pathologic effects in response to infection; these events may lead to organ dysfunction and death. Anti-TNF therapies appear to attenuate the injurious effects of TNF.

Original languageEnglish (US)
JournalCritical Care Medicine
Volume21
Issue number10 SUPPL.
StatePublished - 1993

Fingerprint

Communicable Diseases
Tumor Necrosis Factor-alpha
Infection
Cytokines
Lipopolysaccharides
Information Storage and Retrieval
Chemotaxis
Cell Adhesion
MEDLINE
Blood Vessels
Language
Monoclonal Antibodies
Databases
Pathology
Proteins

Keywords

  • antibodies, monoclonal
  • cytokines
  • endotoxins
  • human immunodeficiency virus
  • malaria
  • recombinant proteins
  • shock, septic
  • tumor necrosis factor

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Tumor necrosis factor in the pathogenesis of infectious diseases. / Beutler, B.; Grau, G. E.

In: Critical Care Medicine, Vol. 21, No. 10 SUPPL., 1993.

Research output: Contribution to journalArticle

@article{9c5c19d7776d4519af600b52b9267ebc,
title = "Tumor necrosis factor in the pathogenesis of infectious diseases",
abstract = "Objectives: To review the immunologic role of the cytokines and the specific role that tumor necrosis factor (TNF) plays in response to infection. The influence of bacterial lipopolysaccharide on TNF, the cytokine cascade, and resultant pathologies are also reviewed. Data Sources: A MEDLINE search of the international English language literature from 1960 to the present was reviewed, but data from the past 5 yrs primarily formed the basis for this review. Study Selection: Those studies detailing the interaction of lipopolysaccharide, TNF, and other cytokines, and their roles in combating infection were emphasized. Investigations that described animal and human results served as the primary database. Data Extraction: Animal studies were selected based on the relevance of the model to the pathogenesis of the human clinical syndrome. Where they provided supportive evidence, patient studies were selected on the basis of study design. Data Synthesis: TNF plays a key role in the normal immune response to infection, limiting the spread of pathogens. Exaggerated physiologic responses occur under the influence of high concentrations of TNF that are released in response to overwhelming infection, resulting in aberrations in coagulation, cell adhesion, chemotaxis/transmigration, and vascular integrity. These pathologic effects may be inhibited by anti-TNF monoclonal antibodies and recombinant soluble receptor inhibitory proteins. Conclusions: TNF exerts both physiologic and pathologic effects in response to infection; these events may lead to organ dysfunction and death. Anti-TNF therapies appear to attenuate the injurious effects of TNF.",
keywords = "antibodies, monoclonal, cytokines, endotoxins, human immunodeficiency virus, malaria, recombinant proteins, shock, septic, tumor necrosis factor",
author = "B. Beutler and Grau, {G. E.}",
year = "1993",
language = "English (US)",
volume = "21",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Tumor necrosis factor in the pathogenesis of infectious diseases

AU - Beutler, B.

AU - Grau, G. E.

PY - 1993

Y1 - 1993

N2 - Objectives: To review the immunologic role of the cytokines and the specific role that tumor necrosis factor (TNF) plays in response to infection. The influence of bacterial lipopolysaccharide on TNF, the cytokine cascade, and resultant pathologies are also reviewed. Data Sources: A MEDLINE search of the international English language literature from 1960 to the present was reviewed, but data from the past 5 yrs primarily formed the basis for this review. Study Selection: Those studies detailing the interaction of lipopolysaccharide, TNF, and other cytokines, and their roles in combating infection were emphasized. Investigations that described animal and human results served as the primary database. Data Extraction: Animal studies were selected based on the relevance of the model to the pathogenesis of the human clinical syndrome. Where they provided supportive evidence, patient studies were selected on the basis of study design. Data Synthesis: TNF plays a key role in the normal immune response to infection, limiting the spread of pathogens. Exaggerated physiologic responses occur under the influence of high concentrations of TNF that are released in response to overwhelming infection, resulting in aberrations in coagulation, cell adhesion, chemotaxis/transmigration, and vascular integrity. These pathologic effects may be inhibited by anti-TNF monoclonal antibodies and recombinant soluble receptor inhibitory proteins. Conclusions: TNF exerts both physiologic and pathologic effects in response to infection; these events may lead to organ dysfunction and death. Anti-TNF therapies appear to attenuate the injurious effects of TNF.

AB - Objectives: To review the immunologic role of the cytokines and the specific role that tumor necrosis factor (TNF) plays in response to infection. The influence of bacterial lipopolysaccharide on TNF, the cytokine cascade, and resultant pathologies are also reviewed. Data Sources: A MEDLINE search of the international English language literature from 1960 to the present was reviewed, but data from the past 5 yrs primarily formed the basis for this review. Study Selection: Those studies detailing the interaction of lipopolysaccharide, TNF, and other cytokines, and their roles in combating infection were emphasized. Investigations that described animal and human results served as the primary database. Data Extraction: Animal studies were selected based on the relevance of the model to the pathogenesis of the human clinical syndrome. Where they provided supportive evidence, patient studies were selected on the basis of study design. Data Synthesis: TNF plays a key role in the normal immune response to infection, limiting the spread of pathogens. Exaggerated physiologic responses occur under the influence of high concentrations of TNF that are released in response to overwhelming infection, resulting in aberrations in coagulation, cell adhesion, chemotaxis/transmigration, and vascular integrity. These pathologic effects may be inhibited by anti-TNF monoclonal antibodies and recombinant soluble receptor inhibitory proteins. Conclusions: TNF exerts both physiologic and pathologic effects in response to infection; these events may lead to organ dysfunction and death. Anti-TNF therapies appear to attenuate the injurious effects of TNF.

KW - antibodies, monoclonal

KW - cytokines

KW - endotoxins

KW - human immunodeficiency virus

KW - malaria

KW - recombinant proteins

KW - shock, septic

KW - tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0027496501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027496501&partnerID=8YFLogxK

M3 - Article

C2 - 8403980

AN - SCOPUS:0027496501

VL - 21

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 10 SUPPL.

ER -